Atlas Trials

Optimum Induction Therapy of Low-risk APL

Clinical trial NCT05832320 · UNKNOWN

Trial details

NCT number
NCT05832320
Sponsor
Peking University People's Hospital
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Acute Promyelocytic LeukemiaInduction TherapyOral
Start date
2023-01-01
Primary completion
2024-12-31
Enrollment
74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.